Yu Yong-hui, Xu Xiao-qun, Wang Yi, Sun Shu-zhen, Chen Yao
Department of Pediatrics, Shandong Provincial Hospital, Shandong University, Jinan 250021.
Chin J Integr Med. 2006 Mar;12(1):32-6. doi: 10.1007/BF02857427.
To investigate the prevention by Tongxinluo capsule (TXL) of vascular lesions and its effect on the levels of protein and gene expression of lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) of vascular wall in rabbits with atherosclerosis (AS), and to explore its possible mechanism against AS.
AS models were established by feeding New Zealand white rabbits with high-cholesterol diet, and 24 immature rabbits were randomly divided into the control group, model group and treated group (treated with TXL capsule). The indexes of total cholesterol (TC) and low density lipoprotein (LDL) levels were measured at the 16th week. The intima thickness and the plaque area of abdominal aorta were quantitatively analyzed by pathological morphological analysis, the expression of macrophage and smooth muscle cell (SMC) in intima were detected by immunohistochemical method and histologic segments were stained by Hematoxilin-Eosin (HE) to identify the degree of atherosclerotic lesion in the model group and the prevention by TXL. The LOX-1 gene and protein expression in abdominal aorta was detected by semi-quantitative RT-PCR and immunohistochemistry, respectively.
In the model group, the levels of TC and LDL were significantly elevated, aortic intima thickened extensively, the intima area enhanced, and macrophages expression increased; the levels of LOX-1 gene and protein expression was up-regulated in endothelium and neo-intima of the abdominal aorta. The treatment with TXL reduced blood lipids, attenuated arterial intimal proliferation, markedly inhibited the expression of macrophage and excessively expressed the level of LOX-1.
TXL has an inhibitory effect on blood lipids, and it can prevent the occurrence of vascular lesion and cure its development, and its protection against AS was possibly associated with a crucial endothelial protective action through lowering the expression of LOX-1 in vascular walls.
研究通心络胶囊(TXL)对动脉粥样硬化(AS)家兔血管病变的预防作用及其对血管壁凝集素样氧化低密度脂蛋白受体-1(LOX-1)蛋白及基因表达水平的影响,并探讨其抗AS的可能机制。
采用高胆固醇饮食喂养新西兰白兔建立AS模型,将24只未成熟家兔随机分为对照组、模型组和治疗组(给予TXL胶囊治疗)。于第16周检测总胆固醇(TC)和低密度脂蛋白(LDL)水平指标。通过病理形态学分析定量分析腹主动脉内膜厚度和斑块面积,采用免疫组织化学方法检测内膜中巨噬细胞和平滑肌细胞(SMC)的表达,并用苏木精-伊红(HE)染色组织切片以鉴定模型组的动脉粥样硬化病变程度及TXL的预防作用。分别采用半定量逆转录聚合酶链反应(RT-PCR)和免疫组织化学方法检测腹主动脉中LOX-1基因和蛋白表达。
模型组中,TC和LDL水平显著升高,主动脉内膜广泛增厚,内膜面积增大,巨噬细胞表达增加;腹主动脉内皮和新生内膜中LOX-1基因和蛋白表达水平上调。TXL治疗可降低血脂,减轻动脉内膜增殖,显著抑制巨噬细胞表达并下调过度表达的LOX-1水平。
TXL对血脂有抑制作用,可预防血管病变的发生并阻止其发展,其抗AS作用可能与通过降低血管壁中LOX-1的表达发挥关键的内皮保护作用有关。